|
Index of reports
> Hospitalization (1020)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine hospitalization. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 1020 Next >>
Possible Vincristine side effects in female
Reported by a physician from Switzerland on 2012-08-27
Patient: female, weighing 87.7 kg (192.9 pounds)
Reactions: Cholecystitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-12
Rituximab
Dosage: concentration 1/mg/ml
Start date: 2011-11-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Other drugs received by patient: Pantoprazole; Exforge HCT; Dipyrone INJ; Bisoprolol Fumarate; Domperidon; Bactrim DS; Acetaminophen; Metformin Hydrochloride
Possible Vincristine side effects in male
Reported by a physician from Netherlands on 2012-08-27
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Cranial Nerve Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Cyclophosphamide
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: third maintenance cycle
Start date: 2010-09-06
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Neupogen
Dosage: third maintenance cycle
Start date: 2010-09-07
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: third maintenance cycle
Administration route: Oral
Start date: 2010-09-06
Rituximab
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Rituximab
Start date: 2010-11-29
End date: 2011-03-21
Vincristine
Dosage: third maintenance cycle
Start date: 2010-09-06
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-23
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-21
Levoleucovorin Calcium
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-21
End date: 2012-05-25
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2012-05-19
End date: 2012-05-19
Methotrexate Disodium
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
Methotrexate Disodium
Start date: 2012-05-25
Prednisone TAB
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-24
Vincristine
Start date: 2012-05-25
Vincristine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-20
Other drugs received by patient: Cytarabine; Calciparine; Ondansetron Hydrochloride; Allopurinol; Valaciclovir HCL; Nexium; Lyrica; Bactrim DS; Emend
Possible Vincristine side effects in 47 year old male
Reported by a physician from France on 2012-08-27
Patient: 47 year old male
Reactions: Respiratory Tract Infection Bacterial, Epstein-Barr Virus Associated Lymphoma, Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-08
Doxorubicin HCL
Start date: 2012-06-11
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
Nexium
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Vincristine
Start date: 2012-06-08
Other drugs received by patient: Previscan; Methotrexate Sodium; Potassium Chloride; Kineret; Kineret; Kineret; Cacit D3; Aspirin; Prednisone TAB; Acetaminophen; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol
Possible Vincristine side effects in 79 year old female
Reported by a physician from Germany on 2012-08-27
Patient: 79 year old female
Reactions: Sciatica, Lumbar Vertebral Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Prednisone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Vincristine side effects in 10 year old male
Reported by a physician from United States on 2012-08-27
Patient: 10 year old male, weighing 76.1 kg (167.4 pounds)
Reactions: Hypersensitivity, Hyperglycaemia, Peripheral Motor Neuropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-05-22
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Other drugs received by patient: Radiation
Possible Vincristine side effects in female
Reported by a physician from Thailand on 2012-08-24
Patient: female, weighing 57.4 kg (126.3 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Prednisone TAB
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Other drugs received by patient: Dexamethasone; Acetaminophen; Ondansetron; Metformin HCL; Ondansetron; Ondansetron; Atenolol; Simvastatin; Benadryl
Possible Vincristine side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 52 year old female
Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: at 50% dosage
Dexamethasone
Indication: Premedication
Methylprednisolone Sodium Succinate
Indication: B Precursor Type Acute Leukaemia
Prednisone TAB
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Vincristine
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine
Possible Vincristine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Vincristine side effects in male
Reported by a physician from Germany on 2012-08-23
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chemotherapy
Diuretics
Mabthera
Dosage: unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-07-28
End date: 2012-07-28
Prednisone TAB
Indication: Chemotherapy
Ramipril
Vincristine
Indication: Chemotherapy
Other drugs received by patient: Torsemide; Allopurinol; Allopurinol; Pantoprazole; Pantoprazole; Potassium Chloride; Metoprolol Tartrate; Potassium Chloride; Ramipril; Hydrochlorothiazide
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: male
Reactions: Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-26
End date: 2012-06-26
Cyclophosphamide
Start date: 2012-07-10
End date: 2012-07-10
Cyclophosphamide
Start date: 2012-06-08
End date: 2012-06-08
Cyclophosphamide
Start date: 2012-06-11
End date: 2012-06-11
Doxorubicine Actavis
Start date: 2012-06-26
End date: 2012-06-29
Doxorubicine Actavis
Start date: 2012-06-11
End date: 2012-06-11
Doxorubicine Actavis
Start date: 2012-07-10
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
End date: 2012-06-11
Mabthera
Start date: 2012-06-26
End date: 2012-06-26
Mabthera
Start date: 2012-06-28
End date: 2012-06-28
Mabthera
Start date: 2012-07-05
End date: 2012-07-05
Mabthera
Start date: 2012-07-10
End date: 2012-07-10
Nexium
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Vincristine
Start date: 2012-06-08
End date: 2012-06-08
Vincristine
Start date: 2012-06-11
End date: 2012-06-11
Vincristine
Start date: 2012-06-26
End date: 2012-06-26
Vincristine
Start date: 2012-07-10
End date: 2012-07-10
Other drugs received by patient: Etoposide; Cacit D3; Aspirin; Acetaminophen; Prednisone TAB; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol; Previscan; Methotrexate Sodium; Potassium Chloride
Possible Vincristine side effects in 17 year old male
Reported by a physician from Poland on 2012-08-23
Patient: 17 year old male
Reactions: Rhabdomyolysis, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Renal Failure, Neutropenia, Clostridial Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cefepime
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Meropenem
Metronidazole
Netromycin
Vancocin Hydrochloride
Vincristine
Indication: Ewing's Sarcoma Metastatic
Other drugs received by patient: Fluconazole; Caspofungin Acetate
Possible Vincristine side effects in female
Reported by a pharmacist from United States on 2012-08-23
Patient: female, weighing 9.1 kg (20.0 pounds)
Reactions: Extravasation, Crying, Infusion Site Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Other drugs received by patient: Lactulose; Zofran; Lidocain / Prilocaine; Miralax; Maxitrol
Possible Vincristine side effects in 18 year old female
Reported by a physician from Slovenia on 2012-08-23
Patient: 18 year old female
Reactions: Pulmonary Haemorrhage, Gastrointestinal Haemorrhage, Injection Site Haemorrhage, Sepsis, Shock Haemorrhagic, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Staphylococcal Bacteraemia, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Heparin
Vincristine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 55.2 kg (121.4 pounds)
Reactions: Unresponsive To Stimuli, Moaning, Neutropenia, Septic Shock, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Start date: 2009-08-21
Methotrexate Sodium
Prednisone
Vincristine
End date: 2012-08-10
Possible Vincristine side effects in male
Reported by a physician from France on 2012-08-22
Patient: male
Reactions: Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-23
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-21
Levoleucovorin Calcium
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-21
End date: 2012-05-26
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2012-05-19
End date: 2012-05-19
Methotrexate Disodium
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-20
Prednisone TAB
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-25
Vincristine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-20
End date: 2012-05-26
Other drugs received by patient: Valaciclovir HCL; Lyrica; Bactrim DS; Emend; Allopurinol; Cytarabine; Ondansetron Hydrochloride; Nexium; Calciparine
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-08-22
Patient:
Reactions: Cystitis Noninfective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1222.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Doxorubicin HCL
Dosage: 81.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Rituximab
Dosage: 611.75 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Velcade
Dosage: 2.11 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-12
End date: 2012-08-09
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 115.7 kg (254.5 pounds)
Reactions: Gastrointestinal Haemorrhage, Cholecystitis Acute, T-Cell Lymphoma, Disseminated Intravascular Coagulation, Pancytopenia, Atrial Fibrillation, Multi-Organ Failure, Sepsis, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: T-Cell Lymphoma
Start date: 2006-09-10
Cyclophosphamide
Indication: T-Cell Lymphoma
Start date: 2006-01-01
Prednisone TAB
Indication: T-Cell Lymphoma
Start date: 2006-01-01
Remicade
Dosage: 3 dose induction followed by maint. q 8 weeks, 300 mg on 29-jun-2006, total 27 infusions
Indication: Rheumatoid Arthritis
Start date: 2001-10-01
End date: 2006-06-29
Vincristine
Indication: T-Cell Lymphoma
Start date: 2006-09-10
Other drugs received by patient: Azulfadine; Lisinopril
Possible Vincristine side effects in female
Reported by a physician from Denmark on 2012-08-21
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Back Pain, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Cyclophosphamide
Dosage: 05/mar/2012: last dose prioe to onset of sae
Start date: 2012-03-05
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Doxorubicin HCL
Start date: 2012-03-05
Mabthera
Dosage: last dose prior to sae was on 13/feb/2012
Start date: 2012-03-05
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Mabthera
Start date: 2012-02-13
Neulasta
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-10
End date: 2012-02-10
Neulasta
Start date: 2012-02-23
Neulasta
Start date: 2012-03-08
Prednisone TAB
Dosage: last dose prior to sae was on 9/mar/2012
Administration route: Oral
Start date: 2012-03-05
Prednisone TAB
Administration route: Oral
Start date: 2012-02-27
End date: 2012-02-27
Prednisone TAB
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-24
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Vincristine
Start date: 2012-03-05
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Other drugs received by patient: Acyclovir; Ondansetron; Tramadol HCL; Lansoprazole; Acyclovir; Lansoprazole; Bactrim
Possible Vincristine side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-21
Patient: 41 year old male
Reactions: Ecthyma, Pseudomonas Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Prednisone TAB
Dosage: unk
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 13.6 kg (29.9 pounds)
Reactions: Contusion, Vomiting, Flatulence, Hypotension, Tachycardia, Gastrointestinal Necrosis, Cardio-Respiratory Arrest, Hypophagia, Abdominal Distension, Bacterial Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: it 2-2.99 yrs 50 mg
Dexamethasone TAB
Dosage: po 3 mg/m2 dose (1.75 bid)
Administration route: Oral
Methotrexate Sodium
Dosage: it 2 mg/m2
PEG-L Asparaginase (Pegaspaegase, Oncospar)
Dosage: iv 2500 units/m2
Vincristine
Dosage: iv 1.5mg/m2 on day 1 and day 8
Possible Vincristine side effects in male
Reported by a consumer/non-health professional from Germany on 2012-08-21
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Cytomegalovirus Infection, Pulmonary Infarction, Lymphoma, Staphylococcal Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Doxorubicin HCL
Dosage: 100 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Filgrastim
Dosage: 48 unk, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-25
End date: 2010-01-15
Mabcampath
Dosage: 30 mg, day 4 and 5 of each cycle 1-3
Indication: T-Cell Lymphoma
Start date: 2009-12-10
End date: 2010-01-15
Prednisone
Dosage: 10 mg, qd (day 1-5)
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-11-27
End date: 2010-01-10
Vincristine
Dosage: 1 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-11-26
End date: 2010-01-11
Other drugs received by patient: Torsemide; Metoprolol Succinate; Heparin; Marcumar; Pantoprazole; Sulfamethoprim
Possible Vincristine side effects in 45 year old female
Reported by a physician from United States on 2012-08-21
Patient: 45 year old female
Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-06-01
Cisplatin
Dosage: unk
Indication: Mycosis Fungoides
Cyclophosphamide
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Daunorubicin HCL
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Dexamethasone
Dosage: unk
Indication: Mycosis Fungoides
Etoposide
Dosage: unk
Indication: Mycosis Fungoides
Fludara
Dosage: 2 cycles
Indication: Mycosis Fungoides
Ifosfamide
Dosage: unk
Indication: Mycosis Fungoides
Prednisone
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Vincristine
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Possible Vincristine side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-21
Patient: 8 year old female
Reactions: Mucoepidermoid Carcinoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in male
Reported by a physician from United Kingdom on 2012-08-20
Patient: male
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1700mg per day
Indication: Richter's Syndrome
Start date: 2012-07-27
End date: 2012-07-27
Doxorubicin Hydrochloride
Dosage: 120mg per day
Indication: Richter's Syndrome
Start date: 2012-07-27
End date: 2012-07-27
Ofatumumab
Indication: Richter's Syndrome
Start date: 2012-07-30
Prednisolone
Dosage: 95mg per day
Administration route: Oral
Indication: Richter's Syndrome
Start date: 2012-07-27
End date: 2012-07-31
Vincristine
Dosage: 2mg per day
Indication: Richter's Syndrome
Start date: 2012-07-27
End date: 2012-07-27
Other drugs received by patient: Voriconazole; Ranitidine; Prednisolone; Sertraline Hydrochloride; Acyclovir
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Vincristine side effects in 3 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-20
Patient: 3 year old male
Reactions: Histiocytosis Haematophagic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 18 mg/m2, cyclic (18 mg/m 2 for 5 days on days 1 to 5)
Cyclophosphamide
Dosage: 1200 mg/m2, cyclic (1200 mg/m2 for 1 day on day 1)
Doxorubicin HCL
Dosage: 25 mg/m2, cyclic (25 mg/m2 for 1 day on day 3)
Vincristine
Dosage: 1.5 mg/m2, cyclic (1.5 mg/m2 for 1 day on day 1)
Other drugs received by patient: Allopurinol; Dalteparin Sodium
Page 1 Next >>
|
